Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10

Arnold, Natalie; Hermanns, Iris M.; Schulz, Andreas et al.

Renin, aldosterone, the aldosterone-to-renin ratio, and incident hypertension among normotensive subjects from the general population

CARDIOVASCULAR RESEARCH. 2022


Plebani, Mario; Gillery, Philippe; Graves, Ronda F. et al.

Rethinking internal quality control: the time is now

CLINICAL CHEMISTRY AND LABORATORY MEDICINE. Bd. 60. H. 9. 2022 S. 1316-1317


Penny, Hugo A.; Domingues, Rita G.; Krauss, Maria Z. et al.

Rhythmicity of intestinal IgA responses confers oscillatory commensal microbiota mutualism

SCIENCE IMMUNOLOGY. Bd. 7. H. 75. 2022


Kraemer, Tobias J.; Huebener, Per; Poettker, Bruno et al.

Ribonuclease-1 treatment after traumatic brain injury preserves blood-brain barrier integrity and delays secondary brain damage in mice

SCIENTIFIC REPORTS. Bd. 12. H. 1. 2022


Riedl, Jana C.; Misirkhanova, Aminat; Musayeva, Aytan et al.

Risk factors for peripheral hypertrophic subepithelial corneal opacification

ACTA OPHTHALMOLOGICA. 2022


Kohls, Natascha; Konstantinides, ?; Lang, Irene Marthe et al.

Risk stratification and risk-adapted management of acute pulmonary embolism

WIENER KLINISCHE WOCHENSCHRIFT. 2022


Hess, Connie N.; Szarek, Michael; Anand, Sonia S. et al.

Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization

JAMA NETWORK OPEN. Bd. 5. H. 6. 2022


Aparicio, Carlos; Polido, Waldemar D.; Chow, James et al.

Round and flat zygomatic implants: effectiveness after a 1-year follow-up non-interventional study

INTERNATIONAL JOURNAL OF IMPLANT DENTISTRY. Bd. 8. H. 1. 2022


Chakrabarty, Sagarika; Bui, Quyen; Badeanlou, Leylla et al.

S1P/S1PR3 signalling axis protects against obesity-induced metabolic dysfunction

ADIPOCYTE. Bd. 11. H. 1. 2022 S. 69-83


Tilch, Marie-Kristin; Robak, Tadeusz; Ghiggi, Chiara et al.

Safety of the Anti-CD19 antibody Tafasitamab in Long Term Responders from A Phase II Trial for Relapsed Lymphoma

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. Bd. 22. H. 4. 2022 S. 270-275